首页>
外国专利>
USE OF FLAVANOLIGNANES FOR THE PREPARATION OF MEDICAMENTS WITH ANTIPROLIFERATIVE ACTIVITY IN UTERUS, OVARY AND BREAST
USE OF FLAVANOLIGNANES FOR THE PREPARATION OF MEDICAMENTS WITH ANTIPROLIFERATIVE ACTIVITY IN UTERUS, OVARY AND BREAST
展开▼
机译:黄酮聚糖在制备子宫,卵巢和乳腺中具有抗增殖活性的药物中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to methods for preventing, inhibiting, or suppressing tumors by administering to a person in need of such treatment a therapeutically effective amount of one or more flavanolignanes, such as silymarin, silybin, silidianin, silicristin, dehydrosilybin, mixtures thereof, or extracts thereof as an antiproliferative. The invention further relates to the antitumor pharmaceutical composition includes a therapeutically effective amount of the flavanolignane selected from the group of silymarin, silybin, silidianin, silicristin, dehydrosilybin, and mixtures thereof, in combination with a different antitumor agent. In another embodiment, the pharmaceutical composition includes a therapeutically effective amount of a flavanolignane selected from the group of silidianin, silicristin, and mixtures thereof, with a pharmaceutically acceptable carrier or excipient. The compositions and method may be prepared or administered with different antitumoral agents for concurrent or sequential use for treating tumors, such as those typically found in the uterus, ovary, and breast.
展开▼